Armata Pharmaceuticals, Inc. Common Stock (ARMP)
Financing Cash Flow
$27.88M
Quarterly · Period ending: · USD
ARMP Financing Cash Flow
Latest reported$27.88Mperiod ending
Latest reported$27.88Mperiod ending
ARMP Quarterly Cash from Financing (-$500.00K → $27.88M)
Quarterly financing cash flow
High-resolution chart · PNG
ARMP financing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 27,881,000 | |
| 641,000 | |
| 658,000 | |
| 14,968,000 | |
| 0 | |
| 9,986,000 | |
| 0 | |
| -61,000 | |
| 88,000 | |
| 34,931,000 | |
| -43,000 | |
| 24,805,000 | |
| -368,000 | |
| 29,594,000 | |
| -500,000 | |
| 31,000 | |
| -146,000 | |
| 44,631,000 | |
| 7,038,000 | |
| 86,000 | |
| -185,000 | |
| 18,579,000 | |
| 432,000 | |
| 60,000 | |
| 306,000 | |
| 22,412,000 | |
| 0 | |
| 0 | |
| 8,970,000 | |
| 5,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -206,000 | |
| -611,000 | |
| 9,693,000 | |
| -205,000 | |
| 3,238,000 | |
| -17,000 | |
| 3,988,000 | |
| 0 | |
| 0 | |
| -1,000 | |
| 397,000 | |
| 12,384,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 18,028,000 | |
| 0 | |
| 7,998,000 | |
| 976,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -258,000 | |
| 0 | |
| -1,000 | |
| -168,000 | |
| -1,177,000 | |
| 17,907,000 | |
| 8,070,000 | |
| -951,000 | |
| 6,000 | |
| -51,000 | |
| 4,748,000 | |
| -33,000 | |
| -2,566,000 | |
| -173,000 | |
| -199,000 | |
| 6,037,000 | |
| -392,000 | |
| -231,000 | |
| 23,556,000 | |
| -210,000 | |
| 4,642,000 | |
| 15,851,000 | |
| -286,000 | |
| 417,000 | |
| 4,615,000 | |
| 5,261,000 | |
| -288,000 | |
| 4,926,278 | |
| 8,194,371 | |
| 2,180,787 | |
| 2,013,564 | |
| 3,337,794 | |
| 5,214,525 | |
| -244,834 | |
| 29,048,740 | |
| 1,000,000 | |
| 6,300,000 | |
| 300,000 | |
| 200,000 | |
| 800,000 | |
| -300,000 | |
| 12,700,000 |